Inspection reliance
Date
Disclaimer
This presentation paper is provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The paper is not legislative in nature and should not be taken to be statements of any law or policy in any way.
The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation paper should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.
Presentation
- Presented by: Stephen Farrell
- Presented at: Online
- Presentation date: 12 May 2021
- Presentation summary: An update of the impact that COVID-19 has had on the GMP Clearance framework, and a review of the broader implications on global inspection reliance.
Webinar presentation: Inspection Reliance (pdf,1671kb)
Topics
-
Insights into Good Clinical Practice (GCP) Inspection Program activities 2023-2024
This webinar provides an overview of TGA’s Good Clinical Practice (GCP) Inspection Program clinical trial compliance activities. -
TGA Advisory Committees: Information for prospective applicants
Are you interested in applying to be a member of one of the TGA’s Statutory Advisory Committees? Hear first-hand from current members and the Chief Medical Adviser about what this exciting role is like. -
Proposed changes to IVD medical device classifications and definitions
Information session for external stakeholders about the proposed IVD regulation changes.